启迪药业(000590.SZ)：前三季度净亏损1482.06万元

Group 1 - The core point of the article is that Qidi Pharmaceutical (000590.SZ) reported its financial results for the first three quarters of 2025, showing a revenue increase but a net loss [1] Group 2 - For the first three quarters of 2025, the company achieved an operating income of 225 million yuan, representing a year-on-year increase of 3.97% [1] - The net profit attributable to shareholders of the listed company was a loss of 14.82 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of 20.68 million yuan, with a basic earnings per share of -0.0619 yuan [1]